Healthcare Expansion
A large Hospital, part of a national system was looking to expand to rural areas.
After analyzing population patterns of the area, it appeared there was a shortage of specialists and clinics available. The client wanted to provide more convenient options for rural patients in small towns, tribal areas and underserved populations and explore options on how to do this.
A medical plaza was planned to bring in specialists on a semi-regular basis rather than bringing in full-time physicians.
Cobalt Crest assisted in setting up a project management timeline to build the health center in a short amount of time and within budget.
We helped identify and recruit specialist physicians, pharmacists, and nurses to staff the new health clinic and help determine optimal schedules for both physicians and the community to ensure services were available for residents in a timely manner but physicians were not being paid to wait for patients. We also suggested an approach for a marketing campaign to inform community residents of the new facility and offerings once they were operational.
An opportunity to expand services for a rural correctional facility was also ideal for utilizing this new facility and the existing contract with Department of Corrections was tripled in size. The clinic has continued expansion for multiple communities in Eastern Oregon and Western Idaho areas.
Software Market Analysis
Our client had worked with the National Health System in UK and wanted to expand their market outside that market. Their software offering utilizes machine learning to create “digital workers” and automate repetitive but necessary tasks. The RPA approach is a simpler approach than Business Process Management and the RPA market is projected to be worth over $25Billion by 2025.
The consulting project illustrated processes that were unique to the US Healthcare market, as well as identified other key markets. In addition to the in depth analysis, we also consulted on website, logo and digital presence and facilitated introductions to key players in healthcare, insurance, pharmaceutical and software companies.
The expansion into the US market was a key to the globalization of the company and their North American presence was a large factor in their public offering and recent takeover valued at over $1.5 billion.
After setting up pilot programs with pulmonologists at various teaching hospitals, it was determined that while the product provided superior results, the number of US based surgeons with resources and interest in the product was limited initially.
As part of strategy, focus was shifted to Asia, where lung disease is more prominent and adoption was more likely. The company received Series C & Series D funding and was added to a Global Small Cap index on the Hong Kong Stock Exchange.